HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Blood rheological effects in ischemic heart disease treated with antianginal and thrombolytic agents].

Abstract
In 161 patients with different forms of ischaemic heart disease the authors studied changes of the blood viscosity, erythrocyte aggregation and of thrombocytes during treatment with modern antianginal and the thrombolytic agents. Treatment with nitroglycerin in tablets and Sustac revealed no statistically significant differences in the changes of the haemorheological parameters. The mainly thrombocyte disaggregational effect was shown by micristin (aspirin/propranolol in the daily dose of over 120 mg) and verapamil (the daily dose over 160 mg). The use of dipyridamol, trental and nonachlazin was accompanied both by the decrease of functional activity of thrombocytes and by the decrease of the blood viscosity as a result of improvement of the functional properties of erythrocytes. Sodium nitroprusside depressed shortly the aggregation of platelets and decreased the blood viscosity at the expense of the decrease of the haematocrit. The use of streptokinase (avelisine) in patients with acute myocardial infarction was accompanied by defibrinisation of the blood, by marked decrease of the aggregation facility of formed elements of the blood and its viscosity. The results suggest that the haemorheological mechanisms participate in the antianginal effect of the drugs studied.
AuthorsM P Savenkov, N A Volov, K I Tebloev
JournalKardiologiia (Kardiologiia) Vol. 21 Issue 8 Pg. 63-9 (Aug 1981) ISSN: 0022-9040 [Print] Russia (Federation)
Vernacular TitleGemoreologisheskie éffekty u bol'nykh ishemicheskoĭ bolezn'iu serdtsa pri lechenii antianginal'nymi i tromboliticheskimi sredstvami.
PMID7289386 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Fibrinolytic Agents
Topics
  • Adult
  • Aged
  • Angina Pectoris (blood, drug therapy)
  • Blood Viscosity (drug effects)
  • Coronary Disease (blood, drug therapy)
  • Female
  • Fibrinolytic Agents (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (blood, drug therapy)
  • Rheology
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: